NCT00265967View on ClinicalTrials.gov

Irbesartan in Hypertension

PHASE4CompletedINTERVENTIONAL

Enrollment

88

Participants

Timeline

Start Date

September 30, 2005

Primary Completion Date

February 28, 2007

Conditions

Hypertension

Interventions

DRUG

Irbesartan

Irbesartan 150-300 mg/d for 8 weeks

Trial Locations (1)

Unknown

Sanofi-Aventis, Istanbul

Sponsors

Lead Sponsor

Collaborators (1)

Bristol-Myers Squibb

All Listed Sponsors

collaborator

Bristol-Myers Squibb

INDUSTRY

lead

Sanofi

INDUSTRY

NCT00265967 - Irbesartan in Hypertension | Biotech Hunter | Biotech Hunter